NABP Collaborates With IBM to Build New Digital Platform to Protect the Drug Supply Chain
IBM News, Thursday, July 27,2023
Pulse by NABP to connect the full supply chain that provides medication to patients in the United States | IBM Consulting supporting NABP with technology expertise to power the inclusive, accessible, and secure digital platform
The National Association of Boards of Pharmacy (NABP) and IBM (NYSE:IBM) Consulting are pleased to announce their collaboration to build Pulse by NABP, a new digital platform that is intended to bring visibility to the drug supply chain and help protect patients from counterfeit or substandard prescription medications.
Launching in late summer 2023, the platform is designed to facilitate manufacturers, wholesalers, pharmacies, and regulators to identify counterfeit or substandard prescription medications and connect with each other when required; provide authorized partners with capabilities to help them accurately trace prescription medications throughout the supply chain; and give patients more confidence that their prescriptions are legitimate.